您搜索了: diphénylspiromustine (法语 - 英语)

la combinaison selon la revendieation 7, selon laquelle ledit agent antinéoplasique du type alkylant est choisi dans le groupe comprenant les suivants:shionogi 254-s, analogues aldo-phosphamides, altrétamine, anaxirone, boehringer mannheim bbr-2207, bestrabucile, budotitane, wakunaga ca-102, carboplatine, carmustine, chinoin-139, chinoin-153, chlorambucile, cisplatine, cyclophosphamide, american cyanamid cl-286558, sanofi cy-233, cyplatate, degussa d-19-384, sumimoto dachp(pyr)2, diphénylspiromustine, diplatine cytostatique, dérivés de erba distamycine, chugai dwa-2114r, iti e09, elmustine, erbamont fce-24517, estramustine phosphate sodium, fotémustine, unimed g-6-m, chinoin gyki-17230, heptsulfame, ifosfamide, iproplatine, lomustine, mafosfamide, mitolactol, nippon kayaku nk-121, nci nsc-264395, nci nsc-342215, oxaliplatine, upjohn pcnu, prednimustine, proter ptt-119, ranimustine, sémustine, smithkline sk&f-101772, yakult honsha sn-22, spiromustine, tanabe seiyaku ta-077, tauromustine, témozolomide, téroxirone, tétraplatine et trimélamol.
the combination of claim 7 wherein said alkylating-type antineoplastic agent is selected from the group consisting of shionogi 254-s, aldo-phosphamide analogues, altretamine, anaxirone, boehringer mannheim bbr-2207, bestrabucil, budotitane, wakunaga ca-102, carboplatin, carmustine, chinoin-139, chinoin-153, chlorambucil, cisplatin, cyclophosphamide, american cyanamid cl-286558, sanofi cy-233, cyplatate, degussa d-19-384, sumimoto dachp(myr)2, diphenylspiromustine, diplatinum cytostatic, erba distamycin derivatives, chugai dwa-2114r, iti e09, elmustine, erbamont fce-24517, estramustine phosphate sodium, fotemustine, unimed g-6-m, chinoin gyki-17230, hepsulfam, ifosfamide, iproplatin, lomustine, mafosfamide, mitolactol, nippon kayaku nk-121, nci nsc-264395, nci nsc-342215, oxaliplatin, upjohn pcnu, prednimustine, proter ptt-119, ranimustine, semustine, smithkline sk&f-101772, yakult honsha sn-22, spiromustine, tanabe seiyaku ta-077, tauromustine, temozolomide, teroxirone, tetraplatin and trimelamol.